Regulation of mechanical coupling in aging myocardium

Active Project Grant Awarded Last action

Award ID
R21AG077036
Recipient
Awarding agency
Obligated
$770,588

Award facts

Assistance listing
93.866 Aging Research
Completion date 81% complete
Originally
Place of performance
Wynnewood, PA 19096, USA

Award details come from USAspending.gov.

Description

Abstract
Age modifies heart structure and function, even in the absence of overt cardiovascular disease. With age-related cardiac remodeling, the heart undergoes extensive cellular and molecular changes that result in a stiffer less compliant heart that experiences an overall decline in function. Yet, the human heart is capable of functioning for decades despite minimal cell turnover or regeneration, suggesting that some mechanisms of age-related cardiac remodeling may be compensatory and beneficial, helping sustain heart function over our life span. Recent evidence indicates the upregulation of cytoskeletal proteins may represent a cardioprotective mechanism in the aging heart. In this exploratory R21 proposal, we hypothesize that enhancing the cytoskeletal connection between N-cadherin and the cortical actin network represents an essential compensatory mechanism to maintain force transmission in the aging mammalian heart. To test this hypothesis, the regulation of vinculin, a force-sensitive cytoskeletal protein, will be investigated during cardiac aging in mice. The following interrelated aims are proposed: (1) to test the hypothesis that ABL kinase is required to maintain mechano- electrical integrity in the aging heart. (2) to test the hypothesis that inhibition of tyrosine phosphorylation of vinculin will perturb N-cadherin-cytoskeletal connection leading to accelerated cardiac aging. The proposed studies will allow mechanistic insight into how the major predisposing factor in heart disease, age, affects the remodeling of N- cadherin junctions and mechanical coupling in the aging heart.

Transactions

Action Obligated Date
Amendment $0
Amendment $0
Amendment $0
Amendment -$73,588
Amendment -$73,588
Amendment -$73,588
Amendment $73,588
Amendment $73,588
Amendment $73,588
Amendment $73,588
Amendment $4,920
Amendment $4,920
Amendment $241,080
Amendment $241,080
Original award $205,000
Show all 15

Subawards

Subrecipient Amount Awarded
Rhode Island Hospital This exploratory R21 project aims to dissect the molecular mechanisms responsible for age-dependent cytoskeletal remodeling and its effects on heart function,… $9,333

Quick answers

Who received award R21AG077036?

R21AG077036 was awarded to Lankenau Institute For Medical Research by National Institute on Aging (National Institutes of Health) on June 15, 2024.

How much is award R21AG077036 worth?

$770,588 has been obligated on R21AG077036.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award